Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2409021 in Type 2 Diabetes Mellitus
NCT00871572Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of adomeglivant in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Mar 2009; status: completed.
02
Drugs
adomeglivant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00871572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871572.